MS
Schmolke, Mirco
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy | Antiviral research |  | 2024 | 65 | 52 | ||
| A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI) | Frontiers in immunology | | 2024 | 26 | 15 | ||
| Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3 | Journal of virology | | 2024 | 160 | 34 | ||
| Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibiotics | Microbiology spectrum | | 2023 | 111 | 45 | ||
| Influenza A virus exploits transferrin receptor recycling to enter host cells | Proceedings of the National Academy of Sciences of the United States of America | | 2023 | 246 | 111 | ||
| Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells | Microbiology spectrum | | 2023 | 113 | 43 | ||
| Silent neonatal influenza A virus infection primes systemic antimicrobial immunity | Frontiers in immunology | | 2023 | 304 | 65 | ||
| A quantitative model for virus uncoating predicts influenza A infectivity | Cell reports | | 2023 | 118 | 26 | ||
| Optimizing the live attenuated influenza A vaccine backbone for high-risk patient groups | Journal of virology | | 2022 | 174 | 209 | ||
| A single respiratory tract infection early in life reroutes healthy microbiome development and affects adult metabolism in a preclinical animal model | npj biofilms and microbiomes | | 2022 | 207 | 101 | ||
| Visualization of respiratory commensal bacteria in context of their natural host environment | Frontiers in Microbiology | | 2021 | 222 | 119 | ||
| Influenza A viruses balance ER stress with host protein synthesis shutoff | Proceedings of the National Academy of Sciences |  | 2021 | 325 | 11 | ||
| Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages | EMBO Reports | | 2020 | 316 | 0 | ||
| Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection | Nature Communications | | 2020 | 397 | 132 | ||
| Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization | eLife | | 2020 | 344 | 180 | ||
| Ménage à trois: virus, host, and microbiota in experimental infection models | Trends in Microbiology | | 2019 | 369 | 462 | ||
| Influenza A Virus Genetic Tools: From Clinical Sample to Molecular Clone | Influenza Virus. Methods in Molecular Biology | | 2018 | 426 | 4 | ||
| Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target | Nature Communications | | 2018 | 429 | 210 | ||
| Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlan | Frontiers in Immunology | | 2018 | 430 | 400 | ||
| H5N1 influenza A virus PB1-F2 relieves HAX-1-mediated restriction of avian virus polymerase PA in human lung cells | Journal of Virology | | 2018 | 264 | 142 | ||
| Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis | Microbiome | | 2018 | 293 | 124 | ||
| RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection | PLOS pathogens | | 2016 | 554 | 242 | ||
| The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA | Journal of virology | | 2015 | 644 | 2 | ||
| Human dendritic cell response signatures distinguish 1918, pandemic and seasonal H1N1 influenza viruses | Journal of virology | | 2015 | 598 | 3 | ||
| Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein | PLOS pathogens | | 2015 | 676 | 274 | ||
| Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency | Science | | 2015 | 708 | 2 | ||
| The origin of the PB1 segment of swine influenza A virus subtype H1N2 determines viral pathogenicity in mice | Virus research | | 2014 | 509 | 304 | ||
| Avian influenza A H10N8--a virus on the verge? | Lancet | | 2014 | 467 | 494 | ||
| A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence | Journal of virology | | 2014 | 538 | 366 | ||
| Divergent H7 immunogens offer protection from H7N9 virus challenge | Journal of virology | | 2014 | 673 | 0 | ||
| RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infection | MBio | | 2014 | 658 | 217 | ||
| Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection | The Journal of biological chemistry | | 2014 | 645 | 233 | ||
| 17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha | Viral immunology | | 2014 | 539 | 226 | ||
| Highly pathogenic influenza viruses inhibit inflammatory response in monocytes via activation of rar-related orphan receptor RORα | Journal of innate immunity | | 2013 | 527 | 0 | ||
| Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility | Nature communications | | 2013 | 561 | 238 | ||
| Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction | Journal of virology | | 2012 | 455 | 206 | ||
| Host modulators of H1N1 cytopathogenicity | PloS one | | 2012 | 516 | 1,333 | ||
| Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export | The Journal of cell biology | | 2012 | 486 | 0 | ||
| Cross-presenting CD103+ dendritic cells are protected from influenza virus infection | The Journal of clinical investigation | | 2012 | 452 | 0 | ||
| The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein | PLOS pathogens | | 2011 | 587 | 256 | ||
| Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species | PLOS pathogens | | 2011 | 515 | 397 | ||
| Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor | Nature chemical biology | | 2011 | 550 | 247 | ||
| H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response | The Journal of immunology | | 2011 | 477 | 0 | ||
| Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein | Journal of virology | | 2010 | 502 | 322 | ||
| Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4) | The Journal of biological chemistry | | 2010 | 491 | 0 | ||
| NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets | Vaccine | | 2010 | 588 | 614 | ||
| PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models | Journal of virology | | 2010 | 588 | 253 | ||
| Evasion of innate and adaptive immune responses by influenza A virus | Cellular microbiology | | 2010 | 537 | 238 | ||
| Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome | The Journal of immunology | | 2009 | 549 | 651 |
